Portfolio company
Neuro
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Mangrove Neuro develops cell and tissue replacement therapies, specifically cortical grafts, for patients suffering from neurodegeneration and brain trauma.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Mangrove
Mangrove Neuro develops cell and tissue replacement therapies, including cortical grafts, to treat neurodegeneration and brain trauma for patients.
BE Therapeutics
This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.
Neurona Therapeutics
This company develops off-the-shelf regenerative neural cell therapies for patients with drug-resistant epilepsy and other chronic disorders of the central nervous system.
Neuroplast
This company develops autologous stem cell therapies to treat patients with neurodegenerative diseases including spinal cord injuries and amyotrophic lateral sclerosis.
Glialign
Glialign develops engineered neural tissue to provide a living nerve-growth guide for the surgical repair of peripheral nerve injuries in patients.
Neuraworx
This company develops a wearable neurostimulation device that enhances the brain's waste clearance system to treat neurodegenerative diseases and traumatic brain injuries.
Reservoir Neuroscience
The company develops therapeutics to repair the blood-brain barrier for patients with age-related neurodegeneration and chronic epilepsy.
NsGene
The company develops encapsulated cell therapy implants to deliver biotherapeutics directly to the brain for patients with neurological and sensorineural disorders.
